Solutio-improved treatment of varicose veins via new medical device for treatment of varicose veins.
| Reference number | |
| Coordinator | MEDVASC AKTIEBOLAG - MedVASC AB |
| Funding from Vinnova | SEK 1 956 000 |
| Project duration | January 2018 - December 2019 |
| Status | Completed |
Important results from the project
The project Solutio is based on using Gold standard existing technology for the treatment of varicose veins, ie minimal-level laser surgery, but in a new and innovative way. We have developed a medtech instrument, Solutio , that allows deployment of anesthetic from within the vessel prior to treatment. There are no pain receptors on the inside of the vessel wall. This will mean simplified pain-free treatment of varicose veins for patients as well as an efficiency and resource-minimized technology for healthcare.
Expected long term effects
In the Solutio project, MedVasc AB has proven that all our assumptions about the development of the technology and the outcome of using the technology have been met. The technical success means that commercial production can be planned for Solutio . The clinical outcome of the study shows that Solutio is a functioning product and that patients and healthcare will in future be able to benefit from the improvements Solutio can offer with streamlining of care for all parties.
Approach and implementation
The project plan has been followed and the time frames have been cleared. Running the project in three parallel tracks with technology development of the product with laboratory and animal experiments at the same time as regulatory planning and information work has gone on has put a strain on the project management. Because of that external consultants have been used to a greater extent than planned. This also includes the design, planning and implementation of the FIM study. Together, this has meant that the cost estimate has not been met but new external money has been added to the project.